In 2025, the number of innovative drug BD transactions in China was quite impressive, accounting for about one - third of the total global BD transactions.
In the past few years, we have invested in more than 30 Chinese innovative pharmaceutical companies and reached BD transactions with more than 10 companies.
The impact of the BD transactions of secondary - market companies on their stock prices needs to be analyzed in combination with the actual situation of the companies.
A customized collection of grant news from foundations and the federal government from around the Web.

In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.